Axolotl Biologix is a finalist in the BioAccel Solutions Challenge

The Solutions Challenge is an annual competition designed by BioAccel to better align market need, with innovation and early investment to stimulate company formation in novel medical technology. The program researches areas of critical healthcare and market need, then challenges entrepreneurs to create innovative solutions to address them.

Axolotl Biologix, Inc. is proud to be a finalist in the BioAccel Solutions Challenge. Axolotl Biolgix, Inc. is a regenerative medicine company that develops and manufactures human cells and tissue products. Axolotl Biologix specialize in products for orthopedic and wound care. The Company's vision is to be an innovative leader in regenerative medicine through research, technology, and clinical application.